QUALITY OF LIFE IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PATIENTS TREATED WITH LENALIDOMIDE VS INVESTIGATOR'S CHOICE: MCL-002 (SPRINT) TRIAL

S. Rule, L. Arcaini, J. Walewski, A. Skotnicki, D. Belada, J. Mayer, J. Alexeeva, B. Afanasyev, A. Kuzmin, W. Jurczak, K. Kaplanov, S. Voloshin, J. Radford, S. Le Gouill, T. Biyukov, M. Patturajan, M. L. Casadebaig-Bravo, D. Mahmoud, X. H. Hu, M. Trneny

    Research output: Contribution to journalArticlepeer-review

    Cite this